Johnson & Johnson is looking to sell its Cerenovus stroke therapy business, according three unnamed people "with knowledge of ...

Johnson & Johnson has put its stroke care business up for sale, aiming for a valuation of more than $1bn, as part of its ...

To give some idea of the sheer size of Johnson & Johnson, a glance at its reported sales figure is revealing. In the fourth ...

We recently published a list of 12 Safe Stocks to Buy for the Long Term in 2025. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other safe stocks to ...

We recently compiled a list of the Retirement Stock Portfolio: 10 Healthcare Stocks to Buy. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the ...

Argus Research analyst David Toung maintained a Buy rating on Johnson & Johnson (JNJ – Research Report) yesterday. The company’s shares closed yesterday at $146.64. Toung covers the Healthcare ...

Johnson & Johnson has increased its dividend ... the biggest being its $13.1 billion all-cash deal for Shockwave Medical. It has deployed, announced, or committed $32 billion into inorganic ...

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

The Chicago Bears are dead-set on changing the culture after years of subpar results. Hiring new head coach Ben Johnson is a big swing at doing just that and bringing winning football back to Chicago.

Good morning and welcome to Johnson & Johnson's Fourth Quarter 2024 ... pumps to treat pediatric patients and FDA clearance of Shockwave's Javelin Peripheral IVL Catheter for the treatment of ...

Johnson & Johnson's Q4 2024 earnings missed ... JNJ has invested heavily in cardiovascular with the acquisitions of Shockwave, and Abiomed, and its strategy seems to have worked.